HARROW HEALTH, INC. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Advisory Agreements (3 contracts)
- Management Agreements (1)
- Marketing Agreements (2)
- Settlement Agreements (2)
- Termination Agreements (2)
- Mutual Termination Agreement, dated October 7, 2022 between ImprimisRx and EyePoint Pharmaceuticals, Inc (Filed With SEC on November 14, 2022)
- MANAGEMENTSERVICES AGREEMENT (Filed With SEC on June 20, 2017)
- STRATEGICSALES & MARKETING AGREEMENT (Filed With SEC on May 2, 2017)
- STRATEGICSALES & MARKETING AGREEMENT (Filed With SEC on April 17, 2017)
- TERMINATION AGREEMENT (Filed With SEC on July 25, 2012)
- AMENDMENT TO ADVISORY AGREEMENT (Filed With SEC on July 25, 2012)
- Senior Advisory Agreement, dated as of January 17, 2012, by and between Imprimis Pharmaceuticals, Inc. and Paul Finnegan, M.D (Filed With SEC on May 10, 2012)
- Waiver and Settlement Agreement, effective as of January 25, 2012, by and between Imprimis Pharmaceuticals, Inc. and DermaStar International, LLC (Filed With SEC on May 10, 2012)
- Waiver and Settlement Agreement, effective as of January 25, 2012, by and between Imprimis Pharmaceuticals, Inc. and Alexej Ladonnikov (Filed With SEC on May 10, 2012)
- Exhibit 10.4 Advisory Agreement (Filed With SEC on April 27, 2012)
